“I think the important thing for folks is we don’t see anything so far that would seem to indicate that it would affect vaccine development,” HHS Sec.
- Azar says he’s still looking at study on virus mutation
- NOTE: Scientists in Houston yesterday released study on more than 5k genetic mutations of coronavirus, Wash. Post
reports
- NOTE: Scientists in Houston yesterday released study on more than 5k genetic mutations of coronavirus, Wash. Post
- All six vaccine candidates are in industrial manufacturing already, Azar says, notes Pfizer, Moderna may see data as soon as late Oct.
- “By end of March, April, we would have enough vaccine, plenty of vaccine for all Americans,” ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.